- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00508508
Effectiveness of Peer Support in Improving Heart Failure Self-Management and Care
Mobilizing Peer Support for Effective Heart Failure Self-Management
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
HF is a life-threatening condition in which the heart can no longer pump enough blood to the rest of the body. It is important for individuals with heart failure to closely monitor their symptoms, seek out medical attention when appropriate, and effectively self-manage their condition. However, people with HF are often frail, poor, and socially isolated. These factors may limit their ability to access clinic-based services and self-manage their condition. Research has shown that group health care visits with other HF patients and peer support for self-care behaviors are effective at improving heath care outcomes. This study will use an interactive voice response (IVR) system, which is a low-cost telephone system that allows calls to be made through a central 1-800 number, thereby eliminating the need to distribute home phone numbers or pay for long distance calls. Through the IVR system, participants will receive and provide peer support by sharing and discussing HF self-management techniques. The IVR system will also facilitate patient communication with care managers. This study will evaluate the effectiveness of the peer-to-peer IVR program in combination with group health care visits led by HF nurses at reducing hospitalization and death rates among HF patients. Participants will be drawn from a community health care system that primarily serves large numbers of racial minority and socioeconomically vulnerable people.
This study will enroll 288 moderate- to high-risk HF patients from St. Joseph Mercy Health System in Ypsilanti, Michigan. Participants will be paired up with another HF patient, based on gender and illness severity. Each pair will be randomly assigned to receive either usual care or usual care plus the nurse-led group visits and the IVR program. Participants using IVR will receive training in peer communication techniques and participate in an initial nurse-led interactive group visit. They will then be asked to communicate at least weekly with their partner using the IVR system. The IVR system will also automatically send reminder calls to participants and allow them to leave voice mail messages for their partner and their care manager. At Months 1, 3, and 6, participants will take part in group visits led by nurses to discuss HF self-management strategies. Study staff will monitor participants' use of the IVR system, including the dates, duration, and recipients of all phone calls. At Months 6 and 12, all participants will complete questionnaires and undergo a medical record review to assess hospitalization and death rates, quality of life, self-management behaviors, social support, satisfaction with HF care, and depression symptoms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ypsilanti, Michigan, United States, 48197
- St. Joseph Mercy Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosed with HF
- Inpatient Hospital stay or Heart Failure Clinic Appointment
Exclusion Criteria:
- Serious mental illness or cognitive dysfunction
- Does not speak English fluently
- Receives most HF care outside the St. Joseph Mercy Health System
- Unable to use the telephone to access the IVR system
- Will be discharged to a long-term care or hospice facility
- End-stage cancer or other end-stage condition
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
Behavioral: IVR
|
Participants using IVR will receive training in peer communication techniques and participate in an initial nurse-led interactive group visit.
They will then be asked to communicate at least weekly with their partner using the IVR system.
The IVR system will also automatically send reminder calls to participants and allow them to leave voice mail messages for their partner and their care manager.
Other Names:
|
Experimental: 2
Behavioral: Nurse-Led Group Visits
|
At Months 1, 3, and 6, participants will take part in group visits led by nurses to discuss HF self-management strategies.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Re-hospitalization and death rates
Time Frame: Measured at Month 12
|
Measured at Month 12
|
Total hospitalizations
Time Frame: Measured at Month 12
|
Measured at Month 12
|
HF-specific quality of life
Time Frame: Measured at Months 6 and 12
|
Measured at Months 6 and 12
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
HF self-management behaviors, treatment regimens, and perceived social support
Time Frame: Measured at Months 6 and 12
|
Measured at Months 6 and 12
|
HF self-care self-efficacy and autonomous motivation
Time Frame: Measured at Months 6 and 12
|
Measured at Months 6 and 12
|
Satisfaction with HF care
Time Frame: Measured at Months 6 and 12
|
Measured at Months 6 and 12
|
Depressive symptoms
Time Frame: Measured at Months 6 and 12
|
Measured at Months 6 and 12
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: M.E. Michele Heisler, MD, University of Michigan, Ann Arbor, Internal Medicine, General Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 429
- 1R01HL085420-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure, Congestive
-
Echosense Ltd.WithdrawnCongestive Heart Failure (CHF)United States
-
Corthera, Inc.(formerly BAS Medical, Inc.), a member...TerminatedCongestive Heart Failure (CHF)Russian Federation
-
Meir Medical CenterUnknown
-
Nihon KohdenTerminatedHeart Failure,CongestiveUnited States
-
Adnan Kastrati, MDBiotronik SE & Co. KGCompleted
-
Signature Medical, Inc.WithdrawnHeart Failure,Congestive
-
Abbott Medical DevicesCompletedCongestive Heart Failure TreatedItaly
-
Echosense Ltd.Terminated
-
ELA Medical, Inc.Approved for marketing
-
Magenta Medical Ltd.TerminatedCongestive Heart Failure | Heart Failure, Congestive | Acute Heart FailureCroatia, Belgium, Serbia
Clinical Trials on Interactive Voice Response System
-
Ottawa Heart Institute Research CorporationHeart and Stroke Foundation of OntarioCompletedCoronary Artery DiseaseCanada
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedLung CancerUnited States
-
M.D. Anderson Cancer CenterCompletedEsophageal Cancer | Lung CancerUnited States
-
University of VermontNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompletedChronic Pain and Relapse PreventionUnited States
-
Michigan State UniversityNational Cancer Institute (NCI)CompletedMelanoma | Leukemia | Breast Neoplasms | Prostatic Neoplasms | Colorectal NeoplasmsUnited States
-
Public Health Foundation of IndiaTerminatedIntervention StudyIndia
-
PfizerCompleted